Indefinite Delivery Contract SPE2DX21D9335
Award Date
9/16/21
Last Date to Order
12/31/25
Federal Agency
Medical Supply Chain
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract was awarded as a single award by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. With a potential value of $499,999,999, the contract supports the Prime Vendor Pharmaceutical Branch in Philadelphia through December 31, 2025. The SPE2DB program aims to procure pharmaceutical products and services for the Defense Logistics Agency through a prime vendor arrangement. DMS Pharmaceutical Group Inc. will deliver pharmaceuticals and manage distribution to...
The Defense Logistics Agency awarded a single-award Indefinite Delivery Contract to DMS Pharmaceutical Group Inc. on January 23, 2020 to provide pharmaceutical products and services to the agency's Philadelphia branch. With a potential value of $4,999,999, the SPE2DB contract has a period of performance through December 24, 2024 for ordering pharmaceutical supplies under catalog or price list 4600080698. As the prime vendor for pharmaceutical products supporting DLA operations in the...
The Indefinite Delivery Contract was awarded as a single award by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc. to serve as the prime vendor for pharmaceutical branch services in Philadelphia. With a potential value of $4,999,999, the contract utilizes no set-asides and has a period of performance through task order delivery by December 30, 2025. Under contract number 4600080777, DMS Pharmaceutical Group Inc. will provide pharmaceutical products and...
The Indefinite Delivery Contract was awarded as a single award by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc. to serve as the prime vendor for pharmaceutical branch services in Philadelphia. With a potential value of $4.999 million, the contract utilizes no set-asides and has a period of performance through last date to order of November 24, 2024. As the prime vendor for pharmaceutical branch services in Philadelphia, DMS Pharmaceutical Group Inc. will...
The contract awarded to DMS Pharmaceutical Group Inc. is an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military...
The single award Indefinite Delivery Contract SPE2DB was issued on May 19, 2022 by the Defense Logistics Agency to provide pharmaceutical products and services. With a potential value of $499,999,999, the contract utilizes no set-asides and has a period of performance through December 31, 2025. DMS Pharmaceutical Group Inc. will serve as the prime vendor for the DLA's Philadelphia branch, supplying pharmaceuticals to support Defense Department operations. The original solicitation sought a...
This single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DX program enables the procurement of a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The prime contractor, DMS Pharmaceutical Group Inc., is a woman-owned small business pharmaceutical wholesaler that provides branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables...
This single-award indefinite delivery contract with a potential value of up to $499,999,999 was awarded to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, by the Defense Logistics Agency. The contract, under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders through December 31, 2025 for a broad range of pharmaceutical products to support the recurring medical supply needs of military health facilities globally. Major categories of goods to...
The Defense Logistics Agency Troop Support Medical awarded a single-award indefinite delivery contract to DMS Pharmaceutical Group Inc. The contract has a potential value of $4,999,999 and a period of performance through November 2024. The contract aims to procure pharmaceutical products through a prime vendor arrangement for the Medical Branch in Philadelphia. As an IDV, task orders will be issued to DMS Pharmaceutical Group Inc. on an as-needed basis to supply various pharmaceuticals and...
The indefinite delivery contract SPE2DX15D9700 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award contract has a ceiling value of $4,999,999.00 and runs through November 12, 2025. Under this contract, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order SPE2DX21D9335-SPE2DX24FNP05 | DMS Pharmaceutical Group Inc. | $715 | 8/27/24 | 9/19/24 | 8/27/24 |